FAQ

The Company’s fiscal year begins on January 1 and ends on December 31. By quarter: Q1 is January 1-March 31, Q2 is April 1-June 30, Q3 is July 1-September 31, and Q4 is October 1-December 31.

Cardiol Therapeutics stock is traded on the NASDAQ Capital Market under the ticker symbol “CRDL”, the Toronto Stock Exchange under the ticker symbol “CRDL”, and the Frankfurt Stock Exchange under the ticker symbol “CT9”.

Our press release archive can be viewed in Press Releases under the Investors section and financial reports are available in Filings & Financials under the Investors section located at our website, CardiolRx.com.

Email us at info@cardiolrx.com and we will answer you as soon as possible.

For inquiries related to changes in share registration or address, lost share certificates, estate transfers, or to advise of duplicate mailings, please contact Cardiol Therapeutics’ Transfer Agent:

Email: clients@odysseytrust.com

Tel: 1-587-885-0960

Odyssey Trust Company
702 – 67 Yonge Street
Toronto, Ontario
Canada M5E 1J8

Typically, the Company’s annual meeting is held in the later part of June, but the date is subject to change at the discretion of the Board of Directors. Go to the Events & Presentations page to check if the date of the next AGM has been formally announced and to see notices from previous meetings and information about previous AGMs.

Trevor Burns, Investor Relations
Email: trevor.burns@cardiolrx.com
Tel: +1 (289) 910-0855

Cardiol Therapeutics Inc.
602-2265 Upper Middle Road East
Oakville, Ontario
Canada L6H 0G5

Please visit the Company’s Investor page.

Please visit the Investor Email Alerts section of Cardiols’s Investor Relations website to be added to the investor email distribution list.

Cardiol Therapeutics Inc.
602-2265 Upper Middle Road East
Oakville, Ontario
Canada L6H 0G5

You can view us by visiting the Team section of our website.

Cardiol Therapeutics Inc. is not hiring at this time. For employment updates, please follow us on LinkedIn.